Remedy Meds Review: Great Pricing Model, One Serious Caveat
Remedy Meds does the one thing most of its competitors will not: it quotes a single flat monthly price with the medication included and no membership fee bolted on. It also received an FDA warning letter in 2025. Both facts belong in the same review.
Last updated: August 3, 2026
Quick Verdict
Remedy Meds has the cleanest pricing structure in the category and a regulatory history you need to look into before enrolling. Its model is genuinely all-inclusive: medication is included in the monthly fee, billed month to month, with no separate membership charge. Published rates are around $299/month for compounded semaglutide and $399/month for compounded tirzepatide, plus a microdose tier quoted around $189/month. It also offers brand-name options at roughly $1,299/month for Ozempic and $1,399/month for Zepbound.
The caveat: the FDA issued Remedy Meds a warning letter dated September 9, 2025, concerning the unlawful sale of unapproved and misbranded drugs to US consumers over the internet. That is a matter of public record on the FDA's website. It is not a court finding, and companies routinely respond and remediate - but it is something you should read yourself and ask the company about directly.
What Is Remedy Meds?
Remedy Meds is a telehealth provider offering compounded semaglutide and tirzepatide for weight management, alongside brand-name GLP-1 options. It markets itself explicitly on the absence of the pricing complexity that characterizes much of the category - its own site leads with "no memberships or hidden fees," free shipping, and certified US pharmacies.
The program includes unlimited clinician access via video or chat, free 48-hour cold-chain FedEx delivery, and monthly check-ins with dose adjustments. It maintains one of the largest Trustpilot review volumes in the category - over thirteen thousand reviews at a four-star rating.
Pricing: The Model Competitors Should Copy
After analyzing a dozen providers in this category, we will say plainly: Remedy Meds' pricing structure is the most honest one we have found.
| Option | Monthly Price | Medication Included? |
|---|---|---|
| Microdose tier (semaglutide or tirzepatide) | ~$189 | Yes |
| Compounded semaglutide | ~$299 | Yes |
| Compounded tirzepatide | ~$399 | Yes |
| Ozempic (brand) | ~$1,299 | Yes |
| Zepbound (brand) | ~$1,399 | Yes |
Three things make this structure better than most:
- Medication is included in the fee. No membership-plus-medication arithmetic. The number you see is the number you pay.
- Billed month to month. No prepaying six or twelve months before you know whether you tolerate the drug - the single biggest risk in this category.
- Flat rate regardless of dose. Your cost does not climb as you titrate up, unlike providers that price by strength.
Worth noting on the brand-name pricing: $1,299 for Ozempic and $1,399 for Zepbound are close to undiscounted retail. Manufacturer self-pay programs - NovoCare for Wegovy at $349-$399/month, LillyDirect for Foundayo from $149/month - are dramatically cheaper for brand-name products. If you want a brand-name GLP-1, do not buy it at these prices. See our Wegovy HD guide and Foundayo review for the direct routes.
One transparency wrinkle worth flagging: an independent review captured in July 2026 noted that the only price Remedy publicly posted at that time was the microdose tier, with the standard tiers requiring you to go further into the process. Publicly posted pricing appears to have varied over time, so verify current rates directly.
The FDA Warning Letter
What the Record Shows
The FDA published a warning letter to Remedy Meds dated September 9, 2025 (reference MARCS-CMS 716830). The stated subject was the unlawful sale of unapproved and misbranded drugs to United States consumers over the internet, in the telehealth context.
This is public information available on the FDA's website in its warning letters database. We are reporting it because a prospective patient should know it exists, not because we are drawing a conclusion from it.
What a Warning Letter Is - and Is Not
It is worth being precise here, because both dismissing and overstating a warning letter would mislead you.
- It is a formal regulatory communication stating the FDA's position that it has identified significant violations. It is not a casual notice.
- It is not a court finding or a determination of guilt. It represents the agency's stated position at that point in time.
- Companies are expected to respond, typically within 15 working days, describing corrective actions. Many warning letters are resolved through remediation.
- It does not automatically mean products were unsafe. "Unapproved and misbranded" are specific regulatory classifications that can involve labeling, marketing claims, or approval status rather than contamination or potency.
- It also should not be waved away. The FDA does not issue warning letters lightly, and the telehealth GLP-1 sector has drawn sustained regulatory attention.
The honest position: this is a meaningful data point that a prospective patient deserves to know, and it is not by itself a verdict on the company's current operations.
How to Evaluate a Provider With a Regulatory History
If you are considering Remedy Meds - or any provider with a regulatory record - here is a practical process rather than a blanket recommendation.
- Read the letter yourself. FDA warning letters are published in full on fda.gov and are searchable by company name. Read what was actually alleged rather than a summary of it.
- Check whether it has been closed out. The FDA publishes close-out letters when it determines a company has completed corrective action. The absence of one is not proof of anything, but its presence is meaningful.
- Ask the company directly. Contact them and ask what the letter concerned and what changed as a result. How a company answers that question - openly, defensively, or not at all - tells you a great deal.
- Ask which pharmacy prepares your medication. This applies to every compounded provider. Ask for the pharmacy name and whether it operates under section 503A or 503B, and verify its licensure with the relevant state board of pharmacy.
- Weigh it against your alternatives. Several providers offer comparable pricing without a regulatory record. If two options are otherwise similar, that is a reasonable tiebreaker.
The broader context matters too. The telehealth GLP-1 sector expanded enormously during the semaglutide shortage and has since faced tightening rules - including the FDA's April 2026 clarification that compounded semaglutide can currently only legally come from 503A pharmacies. Regulatory scrutiny across this industry has been widespread. That is context, not exoneration, but it explains why compliance questions are worth asking of every provider you consider.
The $189 Microdose Tier
Remedy offers a lower-cost microdose tier covering compounded semaglutide or tirzepatide at around $189/month. Before choosing it on price, understand what you are buying.
Microdosing means using doses below the standard therapeutic range studied in clinical trials. Every weight loss figure you have seen for these drugs - roughly 15% for semaglutide, 20-22% for tirzepatide - comes from full therapeutic doses over 64 to 72 weeks. Microdoses have not been studied to those endpoints.
- Reasonable use case: maintenance after you have already reached your goal weight, or a patient who genuinely cannot tolerate standard dosing.
- Poor use case: choosing it as a budget option while expecting trial-level weight loss. Paying $110 less for materially less benefit is not a saving.
- What to ask: what specific dose the tier provides, and what happens to your price if your prescriber recommends increasing to a standard therapeutic dose.
What Is Included
- Medication - included in the monthly price rather than billed separately
- Unlimited clinician access by video or chat
- Monthly check-ins with dose adjustments
- Free 48-hour cold-chain FedEx delivery
- No membership fee layered on top
- Month-to-month billing with no multi-month prepay requirement
Unlimited video access is genuinely above the category norm - many competitors offer only asynchronous messaging. Combined with monthly check-ins, that is a reasonable level of clinical contact for GLP-1 management.
Reputation and User Feedback
Remedy Meds holds a four-star Trustpilot rating across more than thirteen thousand reviews - one of the largest review volumes in the category. Volume at that scale is meaningful; it is harder to manufacture than a few hundred reviews.
Positive feedback tends to focus on pricing clarity, delivery speed, and clinician responsiveness - consistent with the program structure described above. Community discussion has periodically questioned how the pricing can be as low as it is, which is a fair question to put to any provider.
User sentiment does not resolve the regulatory question, and it should not be read as doing so. A company can deliver a good customer experience and still have compliance issues; those are separate evaluations.
Pros and Cons
Pros
- Genuinely all-inclusive pricing - medication included, no membership fee
- Month-to-month billing with no prepay commitment
- Flat rate regardless of dose as you titrate up
- Unlimited clinician access by video and chat
- Free 48-hour cold-chain FedEx delivery
- Over 13,000 Trustpilot reviews at a four-star rating
- Both semaglutide and tirzepatide available
Cons
- FDA warning letter dated September 9, 2025 on public record
- Brand-name pricing (~$1,299-$1,399) is far above manufacturer self-pay
- Publicly posted pricing has been inconsistent over time
- Microdose tier may not deliver trial-level results
- Compounded medications are not covered by insurance
- Compounding rules continue to shift industry-wide
Who It Is Right For
Consider It If You:
- Want one flat price with nothing added and no prepay commitment
- Value unlimited video clinician access over asynchronous-only messaging
- Have read the FDA letter yourself and asked the company about it directly
- Have verified which pharmacy prepares your medication and under which section
- Are new to GLP-1s and need month-to-month flexibility to test tolerance
Look Elsewhere If You:
- Are not comfortable with a provider that has a regulatory record - a completely reasonable position, and alternatives exist at similar pricing
- Want a brand-name GLP-1. Manufacturer self-pay programs cost a fraction of the brand pricing here.
- Want the absolute lowest cost and are willing to prepay - long-term plans elsewhere go lower
- Have insurance covering anti-obesity medication - compounded drugs are never covered
- Are eligible for the Medicare GLP-1 Bridge, at $50/month
Want Flat Pricing Without the Regulatory Question?
If you like the all-inclusive model but would rather choose a provider without a warning letter on record, Coreage Rx offers the same structure - one flat rate from $249/month covering consultation, compounded semaglutide, shipping, and ongoing dose management, with no membership fee and no insurance required.
Frequently Asked Questions
How much does Remedy Meds really cost?
Published rates are around $299/month for compounded semaglutide and $399/month for compounded tirzepatide, with a microdose tier around $189/month. Medication is included in that price - there is no separate membership fee - and billing is month to month. Brand-name options are quoted much higher, around $1,299/month for Ozempic and $1,399/month for Zepbound.
Is there a monthly membership fee with Remedy Meds?
No. This is the program's clearest advantage. The advertised price includes the medication, and there is no separate membership charge layered on top - unlike several major competitors where the medication rate and the program fee are billed separately, roughly doubling the real cost.
Did Remedy Meds get an FDA warning letter?
Yes. The FDA published a warning letter dated September 9, 2025 (reference MARCS-CMS 716830) concerning the unlawful sale of unapproved and misbranded drugs to US consumers over the internet in the telehealth context. It is publicly available in the FDA's warning letters database. A warning letter states the agency's position on identified violations; it is not a court finding, and companies typically respond with corrective actions. Read it yourself and ask the company about it before enrolling.
Is Remedy Meds safe to use?
We are not in a position to certify any provider as safe. What we can tell you is what to check: read the FDA warning letter in full, look for a published close-out letter, ask the company what the letter concerned and what changed, and ask which pharmacy prepares your medication and whether it operates under section 503A or 503B. Verify that pharmacy's licensure with the relevant state board. Those steps apply to every compounded provider, not just this one.
Why are Remedy Meds prices so low?
Compounded medications are generally far cheaper than brand-name equivalents because they are not FDA-approved finished products and do not carry the same development and regulatory costs. That is true across the compounded category, not unique to Remedy. The $299 semaglutide rate is competitive but not an outlier - several providers land in similar territory, and some go lower on long prepay terms.
Should I buy brand-name Ozempic or Zepbound through Remedy Meds?
Probably not at those prices. Quoted rates around $1,299-$1,399/month are close to undiscounted retail. Manufacturer self-pay programs are dramatically cheaper - NovoCare offers Wegovy from $149/month at starting doses and $349-$399 at maintenance, and LillyDirect offers Foundayo from $149/month. If you want a brand-name GLP-1, price the manufacturer route first.
What is the $189 microdose plan?
It is a lower-cost tier using doses below the standard therapeutic range studied in clinical trials. It is most defensible for maintenance after reaching a goal weight, or for patients who cannot tolerate standard dosing. It is a poor choice if you are expecting the 15-22% weight loss the trials describe, since those figures come from full therapeutic doses. Ask what specific dose the tier provides before choosing it.
Disclaimer
This article is for informational purposes only and does not constitute medical or legal advice. HealthyPound is not affiliated with, endorsed by, or sponsored by Remedy Meds. The FDA warning letter referenced is a matter of public record published by the U.S. Food and Drug Administration; we report its existence and stated subject without drawing conclusions about the company's current operations, and readers should consult the FDA's website for the full text and any subsequent updates. Pricing reflects publicly available information at the time of writing and changes frequently - confirm current terms directly with the provider. GLP-1 medications are prescription drugs that should only be used under the supervision of a qualified healthcare provider. Individual results vary. HealthyPound may receive compensation from affiliate partners mentioned in this article; Remedy Meds is not among them. See our affiliate disclosure and full medical disclaimer for more information.